Note 8 – Subsequent Events

The Company has analyzed its operations subsequent to June 30, 2018 and noted the following subsequent events:

On July 2, 2018, the Company also entered into a consulting agreement pursuant to which the Company agreed to issue, provided the consultant is still engaged at the respective time of issuance, (i) within 30 days of the date of the agreement, a warrant to purchase 25,000 shares of common stock of the Company with an exercise price of $7.39 per share, which warrant has an exercise period of 12 months from the date of agreement, (ii) within 30 days of the date of the agreement, a warrant to purchase 25,000 shares of common stock of the Company with an exercise price of $7.39 per share, which warrant has an exercise period of 18 months from the date of the agreement, (iii) upon the three month anniversary of the date of the agreement, a warrant to purchase 25,000 shares of common stock of the Company with an exercise price of $8.75 per share, which warrant has an exercise period of 18 months from the date of the agreement and (iv) upon the six month anniversary of the date of the agreement, a warrant to purchase 25,000 shares of common stock of the Company with an exercise price of $10.00 per share, which warrant has an exercise period of 24 months from the date of the agreement. The warrants issued under this agreement are callable by the Company.

On July 3, 2018, the Company entered into an amendment to a consulting agreement and issued 30,000 shares of common stock of the Company and a warrant to purchase 90,000 shares of common stock of the Company. The warrants are fully vested, are exercisable at $8.50 per share and expire five years from the date of issuance.

On July 5, 2018, the Company issued 773 shares of its common stock upon the exercise of 773 employee options at an exercise price of $4.50 per share. In connection with the exercise, the Company received $3 in proceeds.

On July 31, 2018, the Company issued 1,792 shares of its common stock upon the exercise of 1,792 employee options at an exercise price of $2.52 per share. In connection with the exercise, the Company received $5 in proceeds.

On August 9, 2018, the Company’s Board of Directors approved the issuance of 100,000 options to 1 employee which vests over a three-year period on a quarterly basis to purchase shares of the Company’s common stock at $5.75, the closing share price of the Company’s common stock on the Nasdaq Capital Market on August 9, 2018.